Skip to main navigation Skip to search Skip to main content

Erratum to: Targeting hepatic glutaminase activity to ameliorate hyperglycemia (Nature Medicine, (2018), 24, 4, (518-524), 10.1038/nm.4514)

  • Russell A. Miller
  • , Yuji Shi
  • , Wenyun Lu
  • , David A. Pirman
  • , Aditi Jatkar
  • , Matthew Blatnik
  • , Hong Wu
  • , César Cárdenas
  • , Min Wan
  • , J. Kevin Foskett
  • , Junyoung O. Park
  • , Yiyi Zhang
  • , William L. Holland
  • , Joshua D. Rabinowitz
  • , Morris J. Birnbaum

Research output: Contribution to journalComment/debatepeer-review

Abstract

In the version of this article initially published, the “[13C2]α-ketoglutarate” label on Fig. 1g is incorrect. It should be “[13C5]α-ketoglutarate”. Additionally, in Fig. 3b, the “AAV-GFP” group is missing a notation for significance, and in Fig. 3c, the “AAV-GLS2-sh” group is missing a notation for significance. There should be a double asterisk notating significance in both panels. Finally, in the Fig. 4g legend, “[13C6]UDP-glucose” should be “[13C3]UDP-glucose”, and in the Fig. 4h legend, “[13C6]hexose” should be “[13C3]hexose”. The errors have been corrected in the HTML and PDF versions of this article.

Original languageEnglish (US)
Pages (from-to)1482
Number of pages1
JournalNature Medicine
Volume24
Issue number9
DOIs
StatePublished - Sep 1 2018

All Science Journal Classification (ASJC) codes

  • General Biochemistry, Genetics and Molecular Biology

Fingerprint

Dive into the research topics of 'Erratum to: Targeting hepatic glutaminase activity to ameliorate hyperglycemia (Nature Medicine, (2018), 24, 4, (518-524), 10.1038/nm.4514)'. Together they form a unique fingerprint.

Cite this